Sixty Degree Capital Celebrates Final Close of Fund III, Raising $250M for VC Investment in High-Growth Tech Companies
November 23, 2023 – Sixty Degree Capital is excited to announce the final close of its third venture capital fund, with $250M earmarked for high-growth companies from Series A to pre-IPO stages across enterprise software and healthcare.
Fund III is already actively deploying capital to industry-leading ventures including Cato Networks, Docker, NextPoint, Strive Health, Navan, Aqua Security, Arctic Wolf, and Paperspace, with the latter marking the fund’s initial exit to Digital Ocean. In enterprise tech, Sixty Degree Capital aims to invest in enabling technologies for enterprises such as data & cloud infrastructure, artificial intelligence, developer tools, and cybersecurity. In healthcare, Sixty Degree Capital primarily focuses on therapeutics, health services, medical devices, and diagnostics, seeking to drive value-based care, uncover new modalities, address untreated diseases, and discover first and best-in-class therapeutics.
“Our goal with the third fund is to continue supporting fast-growing, high-impact companies that are developing many of the enabling technologies that power innovation over the next decade. We are grateful for the relationships and quality partnerships we’ve built over the last decade, enabling us to really make an impact and help truly great founders achieve great things.”
– Robert Guo, President, Sixty Degree Capital
“At Sixty Degree Capital, we start with a robust thesis-building process backed by fundamental research and collaboration with our deep advisor network in cloud infrastructure, AI, and software development. This not only helps us select impactful, high-return companies for our LPs, but also enables us to support founders with meaningful strategic advice and growth opportunities.”
– Yatong Li, Managing Director – Technology Investment, Sixty Degree Capital
“The companies we back will drive some of the most important clinical and healthcare outcomes over the next decade across therapeutics, medical services, medical devices, and diagnostics. We’ve built a deep academic bench, and our ability to develop a first-principles opinion about core IP is a critical advantage which helps us back companies with real clinical benefit, ultimately saving lives and generating exceptional returns.”
– Lily Li, Managing Director – Healthcare Investment, Sixty Degree Capital
About Sixty Degree Capital:
Sixty Degree Capital is a North American multi-stage venture capital firm headquartered in Toronto, Canada, with a presence in San Francisco, Silicon Valley and New York, investing across enterprise software and healthcare. In enterprise software, Sixty Degree Capital invests within verticals such as data & cloud infrastructure, artificial intelligence, developer tools, and cybersecurity. In healthcare, Sixty Degree Capital primarily focuses on therapeutics, medical services, medical devices, and diagnostics.
For media inquiries, please contact: